ポスター：次世代のバイオプロセス – CMCのデジタル化とAI利活用によるイノベーションの推進

May 12, 2026

バイオプロセス開発およびCMCは、データ量の増加、実験のハイスループット化、規制要件の高度化によって急速に進化しており、分断されたツールや文書中心のワークフローでは対応が困難となっています。Genedata Biopharma Platformは、上流工程～下流工程～解析ワークフローを統合し、AIの利活用が可能なデータ基盤によって、予測分析と迅速な意思決定をサポートします。

Bioprocess development and CMC are rapidly evolving as life‑science organizations face growing data volumes, high‑throughput experimentation, and increasing regulatory demands. To remain competitive, teams need more than disconnected tools and document‑based workflows. The Genedata Biopharma Platform delivers a unified, enterprise‑scale foundation for digital bioprocessing, transforming fragmented bioprocess and CMC data into structured, traceable, and AI‑ready datasets. 

By connecting upstream, downstream, and analytical workflows in one integrated bioprocess data platform, Genedata enables full data lineage, seamless collaboration, and regulatory‑ready compliance. Automated lab workflows, high‑throughput data capture, and instant, data‑driven reporting accelerate development while reducing risk. Built to support AI‑enabled CMC, the platform empowers teams to apply purpose‑built AI and machine learning across thousands of experiments, unlocking predictive insights and faster decision‑making.